{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:33:29Z","timestamp":1792989209512,"version":"4.5.0"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202303041540"],"award-info":[{"award-number":["202303041540"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574790"],"award-info":[{"award-number":["82574790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374237"],"award-info":[{"award-number":["82374237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.critrevonc.2025.104918","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T15:05:41Z","timestamp":1756566341000},"page":"104918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Decoding the AML1\/ETO translocation cipher: In-depth exploration into the pathogenesis and cutting-edge therapeutic strategies of t(8;21) acute myeloid leukemia"],"prefix":"10.1016","volume":"215","author":[{"given":"Changnian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-2388","authenticated-orcid":false,"given":"Siyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104918_bib1","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.2147\/IJN.S467733","article-title":"Fe(3)O(4)-Coated CNTs-Gum arabic Nano-Hybrid composites exhibit enhanced Anti-Leukemia potency against AML cells via ROS-Mediated signaling","volume":"19","author":"Abdel Halim","year":"2024","journal-title":"Int J. Nanomed."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41375-019-0551-4","article-title":"Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)","volume":"34","author":"Agrawal","year":"2020","journal-title":"Leukemia"},{"issue":"44","key":"10.1016\/j.critrevonc.2025.104918_bib3","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1073\/pnas.0802696105","article-title":"Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis","volume":"105","author":"Ahn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1172\/JCI17595","article-title":"Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair","volume":"112","author":"Alcalay","year":"2003","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030307","article-title":"Gene expression profiling and protein analysis reveal suppression of the C-Myc oncogene and inhibition JAK\/STAT and PI3K\/AKT\/mTOR signaling by thymoquinone in acute myeloid leukemia cells","volume":"15","author":"Almajali","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.critrevonc.2025.104918_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fonc.2016.00078","article-title":"Protein phosphatase 2A as a therapeutic target in acute myeloid leukemia","volume":"6","author":"Arriazu","year":"2016","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.exphem.2008.05.008","article-title":"AML1\/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation","volume":"36","author":"Balkhi","year":"2008","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/epi.23538","article-title":"Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1\/ETO-positive leukemia cells","volume":"8","author":"Barbetti","year":"2013","journal-title":"Epigenetics"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.onc.1210820","article-title":"Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1\/ETO-positive cells","volume":"27","author":"Barbetti","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.49","article-title":"AML1\/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia","volume":"4","author":"Barbetti","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.exphem.2005.03.007","article-title":"STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade","volume":"33","author":"Beghini","year":"2005","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/meth.1998.0733","article-title":"Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis","volume":"17","author":"Behre","year":"1999","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.celrep.2013.08.020","article-title":"Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1","volume":"4","author":"Ben-Ami","year":"2013","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib14","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3324\/haematol.13044","article-title":"Transcriptional upregulation of p21\/WAF\/Cip1 in myeloid leukemic blasts expressing AML1-ETO","volume":"93","author":"Berg","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00277-023-05552-4","article-title":"A multicenter phase ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes\/neoplasms or acute myeloid leukemia refractory to hypomethylating agents","volume":"103","author":"Bewersdorf","year":"2024","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood-2013-03-488114","article-title":"Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors","volume":"123","author":"Bots","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/leu.2013.376","article-title":"Pontin is a critical regulator for AML1-ETO-induced leukemia","volume":"28","author":"Breig","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4161\/epi.27322","article-title":"Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1\/ETO target gene IL3","volume":"9","author":"Buchi","year":"2014","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.leukres.2011.11.024","article-title":"Proteomic analysis identifies differentially expressed proteins in AML1\/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine","volume":"36","author":"Buchi","year":"2012","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.10758","article-title":"Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia","volume":"92","author":"Bug","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)00042-X","article-title":"Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo","volume":"13","author":"Cai","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib23","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/cam4.913","article-title":"Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase-3-mediated cleavage of the AML1-ETO oncoprotein","volume":"5","author":"Cao","year":"2016","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800314","article-title":"Polyphyllin I inhibits proliferation and induces apoptosis by downregulating AML1-ETO and suppressing C-KIT\/Akt signaling in t(8;21) acute myeloid leukemia","volume":"15","author":"Chai","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/febs.14751","article-title":"The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter","volume":"286","author":"Chen","year":"2019","journal-title":"Febs J."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.31083\/j.fbl2809195","article-title":"Oridonin synergistically enhances the Pro-Apoptotic effect of venetoclax on acute myeloid leukemia cells by inhibiting AKT signaling","volume":"28","author":"Chen","year":"2023","journal-title":"Front Biosci. (Landmark Ed."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103033","article-title":"FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib28","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1158\/1535-7163.MCT-15-1006","article-title":"BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT-Driven myeloid leukemia","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104918_bib29","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.267278.115","article-title":"JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev."},{"issue":"42","key":"10.1016\/j.critrevonc.2025.104918_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213718119","article-title":"LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib31","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/stem.2348","article-title":"Rac1 GTPase promotes interaction of hematopoietic Stem\/Progenitor cell with niche and participates in leukemia initiation and maintenance in mouse","volume":"34","author":"Chen","year":"2016","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1756-8722-6-72","article-title":"IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells","volume":"6","author":"Chen","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104918_bib33","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2012-11-466219","article-title":"Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells","volume":"121","author":"Chen","year":"2013","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104918_bib34","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1038\/s41388-021-01818-1","article-title":"YTHDF2 is a potential target of AML1\/ETO-HIF1\u03b1 loop-mediated cell proliferation in t(8;21) AML","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2012-01-403212","article-title":"The thrombopoietin\/MPL\/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO","volume":"120","author":"Chou","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib36","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood-2010-01-264119","article-title":"N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene","volume":"117","author":"Chou","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood-2018-05-852822","article-title":"Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients","volume":"133","author":"Christen","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib38","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101681","article-title":"Development of siRNA-Loaded lipid nanoparticles targeting long Non-Coding RNA LINC01257 as a novel and safe therapeutic approach for t(8;21) pediatric acute myeloid leukemia","volume":"13","author":"Connerty","year":"2021","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104918_bib40","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1182\/blood-2008-07-166090","article-title":"Identification of AML1-ETO modulators by chemical genomics","volume":"113","author":"Corsello","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104918_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)01172-1","article-title":"The ETO (MTG8) gene family","volume":"303","author":"Davis","year":"2003","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib42","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1182\/blood-2007-07-103291","article-title":"Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival","volume":"111","author":"Dayyani","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/fon.10.158","article-title":"RUNX1 translocations and fusion genes in malignant hemopathies","volume":"7","author":"De Braekeleer","year":"2011","journal-title":"Future Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib44","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/10428194.2013.815351","article-title":"RUNX1-ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development","volume":"55","author":"DeKelver","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104918_bib45","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2012-11-465641","article-title":"Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential","volume":"121","author":"DeKelver","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11010-022-04554-6","article-title":"Chidamide works synergistically with dasatinib by inducing cell-cycle arrest and apoptosis in acute myeloid leukemia cells","volume":"478","author":"Deng","year":"2023","journal-title":"Mol. Cell Biochem"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib47","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3324\/haematol.2018.205351","article-title":"Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation","volume":"104","author":"Di Genua","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/03009734.2018.1440037","article-title":"MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death","volume":"123","author":"Ding","year":"2018","journal-title":"Ups. J. Med Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1139\/bcb-2018-0017","article-title":"MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells","volume":"96","author":"Ding","year":"2018","journal-title":"Biochem Cell Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib51","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1038\/s41467-019-12960-6","article-title":"Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia","volume":"10","author":"Dou","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib52","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/febs.15102","article-title":"Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells","volume":"287","author":"Du","year":"2020","journal-title":"Febs J."},{"issue":"45","key":"10.1016\/j.critrevonc.2025.104918_bib53","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1038\/sj.onc.1209638","article-title":"siRNA-mediated AML1\/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts","volume":"25","author":"Dunne","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08586.x","article-title":"Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1\/ETO (RUNX1\/RUNX1T1), during myeloid differentiation","volume":"153","author":"Duque-Afonso","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib55","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/ijc.35134","article-title":"Identification of epigenetic modifiers essential for growth and survival of AML1\/ETO-positive leukemia","volume":"155","author":"Duque-Afonso","year":"2024","journal-title":"Int J. Cancer"},{"issue":"27","key":"10.1016\/j.critrevonc.2025.104918_bib56","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1038\/onc.2011.32","article-title":"The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1\/ETO","volume":"30","author":"Duque-Afonso","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib57","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.leu.2404645","article-title":"Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts","volume":"21","author":"Durual","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.104918_bib58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.gene.2019.03.055","article-title":"The prognostic significance of the long non-coding RNAs \"CCAT1, PVT1\" in t(8;21) associated acute myeloid leukemia","volume":"707","author":"El-Khazragy","year":"2019","journal-title":"Gene"},{"issue":"36","key":"10.1016\/j.critrevonc.2025.104918_bib59","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1038\/sj.onc.1206673","article-title":"The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner","volume":"22","author":"Els\u00e4sser","year":"2003","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104918_bib60","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/bloodadvances.2017006148","article-title":"Agonistic targeting of TLR1\/TLR2 induces p38 MAPK-dependent apoptosis and NF\u03baB-dependent differentiation of AML cells","volume":"1","author":"Eriksson","year":"2017","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib61","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.3993","article-title":"Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors","volume":"21","author":"Esposito","year":"2015","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib62","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1073\/pnas.1121341109","article-title":"Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells","volume":"109","author":"Fang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"35","key":"10.1016\/j.critrevonc.2025.104918_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300698","article-title":"Protein-Nanocaged selenium induces t(8;21) leukemia cell differentiation via epigenetic regulation","volume":"10","author":"Fang","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2007.09.020","article-title":"Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1\/ETO oncoprotein","volume":"12","author":"Fazi","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12943-017-0692-x","article-title":"The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia","volume":"16","author":"Fernando","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2009.11.020","article-title":"DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia","volume":"17","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib67","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.onc.1202459","article-title":"The t(8;21) fusion protein, AML1\/ETO, transforms NIH3T3 cells and activates AP-1","volume":"18","author":"Frank","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib68","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/febs.12673","article-title":"AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia","volume":"281","author":"Fu","year":"2014","journal-title":"Febs J."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10428194.2013.805759","article-title":"Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia","volume":"55","author":"Fu","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/leu.2017.300","article-title":"Dual inhibition of EZH1\/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia","volume":"32","author":"Fujita","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbrc.2007.03.009","article-title":"c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression","volume":"356","author":"Gao","year":"2007","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055481","article-title":"A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib73","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2015.56","article-title":"AML1\/ETO cooperates with HIF1\u03b1 to promote leukemogenesis through DNMT3a transactivation","volume":"29","author":"Gao","year":"2015","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000275","article-title":"AML1\/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets","volume":"4","author":"Gardini","year":"2008","journal-title":"PLoS Genet"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib75","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","article-title":"Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO","volume":"18","author":"Gelmetti","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/epi.5.8.13276","article-title":"Strategies to re-express epigenetically silenced p15(INK4b) and p21(WAF1) genes in acute myeloid leukemia","volume":"5","author":"Geyer","year":"2010","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41408-023-00810-0","article-title":"ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias","volume":"13","author":"Golovine","year":"2023","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib78","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/leu.2015.275","article-title":"UBASH3B\/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO","volume":"30","author":"Goyama","year":"2016","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104918_bib79","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1038\/onc.2016.416","article-title":"Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia","volume":"36","author":"Goyama","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00277-005-0006-z","article-title":"Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts","volume":"84","author":"Gozzini","year":"2005","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib81","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2018.05.007","article-title":"CARM1 is essential for myeloid leukemogenesis but dispensable for normal hematopoiesis","volume":"33","author":"Greenblatt","year":"2018","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104918_bib82","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1073\/pnas.1531730100","article-title":"An activated receptor tyrosine kinase, TEL\/PDGFbetaR, cooperates with AML1\/ETO to induce acute myeloid leukemia in mice","volume":"100","author":"Grisolano","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40164-023-00383-5","article-title":"Synergistic effect of HDAC inhibitor chidamide with cladribine on cell cycle arrest and apoptosis by targeting HDAC2\/c-Myc\/RCC1 axis in acute myeloid leukemia","volume":"12","author":"Gu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib84","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1128\/MCB.00073-09","article-title":"Multivalent binding of the ETO corepressor to e proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery","volume":"29","author":"Guo","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104918_bib85","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1074\/jbc.RA119.010707","article-title":"Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML","volume":"295","author":"Guo","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cncr.34534","article-title":"Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia","volume":"129","author":"Han","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20150524","article-title":"Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles","volume":"213","author":"Hatlen","year":"2016","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib88","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.4049\/jimmunol.165.12.6816","article-title":"Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive t cells","volume":"165","author":"Hayashi","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1079-9796(03)00021-4","article-title":"The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor","volume":"30","author":"Hiebert","year":"2003","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jgg.2020.04.006","article-title":"DNA methyltransferases in hematological malignancies","volume":"47","author":"Hoang","year":"2020","journal-title":"J. Genet Genom."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib91","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.leu.2404752","article-title":"The wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis","volume":"21","author":"Hosen","year":"2007","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib92","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4103\/0366-6999.182838","article-title":"Epigenetic silencing of eyes absent 4 gene by acute myeloid leukemia 1-Eight-twenty-one oncoprotein contributes to leukemogenesis in t(8;21) acute myeloid leukemia","volume":"129","author":"Huang","year":"2016","journal-title":"Chin. Med J."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib93","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00432-016-2160-1","article-title":"Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells","volume":"142","author":"Hui","year":"2016","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MPH.0b013e3181c29c3c","article-title":"Dense methylation of types 1 and 2 regulatory regions of the CD10 gene promoter in infant acute lymphoblastic leukemia with MLL\/AF4 fusion gene","volume":"32","author":"Ikawa","year":"2010","journal-title":"J. Pedia Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib95","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/cas.13062","article-title":"Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies","volume":"107","author":"Imai","year":"2016","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib96","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12185-015-1762-8","article-title":"The RUNX1-PU.1 axis in the control of hematopoiesis","volume":"101","author":"Imperato","year":"2015","journal-title":"Int J. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib97","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4161\/cc.4.6.1717","article-title":"Mechanisms of selective anticancer action of histone deacetylase inhibitors","volume":"4","author":"Insinga","year":"2005","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2005","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib99","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5287","article-title":"Epigenetic modifications in acute myeloid leukemia: the emerging role of circular RNAs (Review)","volume":"59","author":"Issah","year":"2021","journal-title":"Int J. Oncol."},{"issue":"51","key":"10.1016\/j.critrevonc.2025.104918_bib100","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.C000485200","article-title":"Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1\/ETO leukemia-associated fusion protein","volume":"275","author":"Jakubowiak","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib101","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.apsb.2022.02.028","article-title":"Erratum: author correction to \"development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers\" [Acta Pharmaceutica Sinica B 11 (2021) 355-372","volume":"12","author":"Jiang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2025.104918_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175957","article-title":"Platycodin d induces apoptotic cell death through PI3K\/AKT and MAPK\/ERK pathways and synergizes with venetoclax in acute myeloid leukemia","volume":"956","author":"Jiang","year":"2023","journal-title":"Eur. J. Pharm."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072335","article-title":"A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib104","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/leu.2009.104","article-title":"AML1-ETO9a is correlated with C-KIT overexpression\/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2","volume":"23","author":"Jiao","year":"2009","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104918_bib105","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/onc.2012.204","article-title":"AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40164-021-00204-7","article-title":"MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3\u2032UTR","volume":"10","author":"Johnson","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib107","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.leu.2403069","article-title":"Transforming growth factor-beta signaling in normal and malignant hematopoiesis","volume":"17","author":"Kim","year":"2003","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104918_bib108","doi-asserted-by":"crossref","first-page":"14059","DOI":"10.1073\/pnas.93.24.14059","article-title":"The AML1\/ETO fusion protein activates transcription of BCL-2","volume":"93","author":"Klampfer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib109","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.leu.2402776","article-title":"Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1\/ETO-positive leukemic cells","volume":"17","author":"Klisovic","year":"2003","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib110","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/leu.2017.67","article-title":"Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/gcc.20165","article-title":"MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21)","volume":"43","author":"Kozu","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib112","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1096\/fj.06-8050com","article-title":"Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARalpha","volume":"22","author":"Kr\u00e4mer","year":"2008","journal-title":"Faseb J."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib113","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2007-06-093682","article-title":"p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death","volume":"111","author":"Krejci","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110481","article-title":"Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML","volume":"38","author":"Krivdova","year":"2022","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104918_bib115","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/sj.onc.1205322","article-title":"Tumor suppressor genes in normal and malignant hematopoiesis","volume":"21","author":"Krug","year":"2002","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib116","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4161\/cc.4.12.2256","article-title":"AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia","volume":"4","author":"Kuchenbauer","year":"2005","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib117","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1532\/IJH97.06070","article-title":"AML1\/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis","volume":"84","author":"Kurokawa","year":"2006","journal-title":"Int. J. Hematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib118","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1349-7006.2003.tb01364.x","article-title":"Role of AML1\/Runx1 in the pathogenesis of hematological malignancies","volume":"94","author":"Kurokawa","year":"2003","journal-title":"Cancer Sci."},{"issue":"36","key":"10.1016\/j.critrevonc.2025.104918_bib119","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1038\/onc.2008.134","article-title":"Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the children's oncology group","volume":"27","author":"LaFiura","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib120","article-title":"Understanding the wnt signaling pathway in acute myeloid leukemia stem cells: a feasible key against relapses","volume":"12","author":"L\u00e1inez-Gonz\u00e1lez","year":"2023","journal-title":"Biol. (Basel)"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190400007565","article-title":"The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia","volume":"46","author":"Larizza","year":"2005","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib122","first-page":"1283","article-title":"A new D816c-KIT gene mutation in refractory AML1-ETO leukemia","volume":"91","author":"Lasa","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib123","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41401-023-01196-2","article-title":"Combination of eriocalyxin b and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML","volume":"45","author":"Lei","year":"2024","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.critrevonc.2025.104918_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exphem.2018.02.001","article-title":"A regulatory circuitry between miR-193a\/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia","volume":"61","author":"Li","year":"2018","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/CAD.0000000000001655","article-title":"EP-0108A is a moderation selectively BRD4 BD2 inhibitor with potential AML tumor suppression","volume":"36","author":"Li","year":"2025","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.critrevonc.2025.104918_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.70090","article-title":"The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation","author":"Li","year":"2025","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib127","doi-asserted-by":"crossref","first-page":"933","DOI":"10.15252\/emmm.201607180","article-title":"A novel epigenetic AML1-ETO\/THAP10\/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis","volume":"9","author":"Li","year":"2017","journal-title":"EMBO Mol. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-626671","article-title":"Genome-wide studies identify a novel interplay between AML1 and AML1\/ETO in t(8;21) acute myeloid leukemia","volume":"127","author":"Li","year":"2016","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104918_bib129","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2015-04-639062","article-title":"Overexpression and knockout of miR-126 both promote leukemogenesis","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.critrevonc.2025.104918_bib130","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1038\/sj.onc.1204593","article-title":"AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML","volume":"20","author":"Licht","year":"2001","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib131","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2016-11-750976","article-title":"A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program","volume":"130","author":"Lin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104918_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.leukres.2018.02.017","article-title":"ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation","volume":"68","author":"Liu","year":"2018","journal-title":"Leuk. Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib133","doi-asserted-by":"crossref","first-page":"827","DOI":"10.21037\/tcr.2019.12.07","article-title":"Chidamide inhibits t(8;21) AML cell proliferation and AMK1\/ETO and C-KIT expression by inhibiting ERK1\/2 signaling pathway","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/leu.2011.178","article-title":"PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1-ETO fusion gene","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/jpet.106.118406","article-title":"Targeting AML1\/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1\/ETO-positive acute myeloid leukemia cells","volume":"321","author":"Liu","year":"2007","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib136","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/0008-5472.CAN-04-4532","article-title":"Interplay of RUNX1\/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib137","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bulcan.2023.01.017","article-title":"Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells","volume":"110","author":"Liu","year":"2023","journal-title":"Bull. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib138","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2007.04.010","article-title":"Structural basis for recognition of SMRT\/N-CoR by the MYND domain and its contribution to AML1\/ETO's activity","volume":"11","author":"Liu","year":"2007","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2006.03.012","article-title":"The tetramer structure of the nervy homology two domain, NHR2, is critical for AML1\/ETO's activity","volume":"9","author":"Liu","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2025.104918_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216980","article-title":"Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3","volume":"594","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib141","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/leu.2013.197","article-title":"JAK inhibitors suppress t(8;21) fusion protein-induced leukemia","volume":"27","author":"Lo","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib142","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2011-12-395335","article-title":"Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML","volume":"120","author":"Lo","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib143","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.leu.2405020","article-title":"Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity","volume":"22","author":"Lu","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib144","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.leu.2404218","article-title":"Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis","volume":"20","author":"Lu","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.19.01053","article-title":"Valproate and retinoic acid in combination with decitabine in elderly nonfit patients with acute myeloid leukemia: results of a multicenter, randomized, 2 \u00d7 2, phase II trial","volume":"38","author":"L\u00fcbbert","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2125748","article-title":"BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes","volume":"23","author":"Ma","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib147","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood-2006-02-003517","article-title":"Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis","volume":"109","author":"Ma","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib148","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2643-3230.BCD-20-0188","article-title":"Hyperthermia selectively destabilizes oncogenic fusion proteins","volume":"2","author":"Maimaitiyiming","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104918_bib149","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1182\/blood-2016-10-745034","article-title":"Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner","volume":"129","author":"Man","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib150","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.celrep.2016.08.082","article-title":"The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t(8;21) AMLs","volume":"17","author":"Mandoli","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib151","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/MCB.19.5.3635","article-title":"Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias","volume":"19","author":"Mao","year":"1999","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib152","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ccell.2018.08.015","article-title":"The oncogenic transcription factor RUNX1\/ETO corrupts cell cycle regulation to drive leukemic transformation","volume":"34","author":"Martinez-Soria","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib153","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12885-023-10818-1","article-title":"Esculetin releases maturation arrest and induces terminal differentiation in leukemic blast cells by altering the wnt signaling axes","volume":"23","author":"Mathur","year":"2023","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib154","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2012-02-411827","article-title":"High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia","volume":"120","author":"Metzeler","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41375-019-0578-6","article-title":"Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)","volume":"34","author":"Meyer","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib156","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/CNV-120018821","article-title":"AML1 interconnected pathways of leukemogenesis","volume":"21","author":"Michaud","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.critrevonc.2025.104918_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15429","article-title":"ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia","volume":"8","author":"Micol","year":"2017","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104918_bib158","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4161\/cc.10.23.18210","article-title":"Sensitivity of acute myeloid leukemia Kasumi-1 cells to binase toxic action depends on the expression of KIT and \u0410ML1-ETO oncogenes","volume":"10","author":"Mitkevich","year":"2011","journal-title":"Cell Cycle"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104918_bib159","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1093\/nar\/23.14.2762","article-title":"Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia","volume":"23","author":"Miyoshi","year":"1995","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib160","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf072","article-title":"AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression","volume":"117","author":"Mou","year":"2025","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib161","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/MCB.24.7.2890-2904.2004","article-title":"Translocation products in acute myeloid leukemia activate the wnt signaling pathway in hematopoietic cells","volume":"24","author":"M\u00fcller-Tidow","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib162","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.0404701102","article-title":"AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion","volume":"102","author":"Mulloy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"800","key":"10.1016\/j.critrevonc.2025.104918_bib163","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.add7705","article-title":"IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the wnt and notch pathways","volume":"16","author":"Naef","year":"2023","journal-title":"Sci. Signal"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104918_bib164","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/bloodadvances.2019000756","article-title":"Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor","volume":"3","author":"Nieborowska-Skorska","year":"2019","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib165","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2005-04-1656","article-title":"AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the wilms tumor gene, WT1","volume":"107","author":"Nishida","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib166","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1080\/10428194.2017.1410882","article-title":"A tool compound targeting the core binding factor runt domain to disrupt binding to CBF\u03b2 in leukemic cells","volume":"59","author":"Oo","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104918_bib167","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1073\/pnas.0902449106","article-title":"A drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO","volume":"106","author":"Osman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104918_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106727","article-title":"A concise review on the molecular genetics of acute myeloid leukemia","volume":"111","author":"Padmakumar","year":"2021","journal-title":"Leuk. Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib169","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","article-title":"Synthetic lethality of combined Bcl-2 inhibition and p53 activation in AML: mechanisms and superior antileukemic efficacy","volume":"32","author":"Pan","year":"2017","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104918_bib170","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2012-02-413187","article-title":"Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes","volume":"123","author":"Pattabiraman","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib171","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/sj.leu.2404849","article-title":"The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation","volume":"21","author":"Peterson","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib172","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1182\/blood-2006-03-012575","article-title":"The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO","volume":"109","author":"Peterson","year":"2007","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104918_bib173","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","article-title":"The 8;21 translocation in leukemogenesis","volume":"23","author":"Peterson","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib174","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/1535-7163.MCT-12-1039","article-title":"Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis","volume":"12","author":"Petruccelli","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2025.104918_bib175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2016.11.021","article-title":"Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells","volume":"386","author":"Piao","year":"2017","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib176","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2009-08-240101","article-title":"Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia","volume":"115","author":"Pulikkan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104918_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115459","article-title":"HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90","volume":"417","author":"Qi","year":"2021","journal-title":"Toxicol. Appl. Pharm."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700162","article-title":"The wnt transcriptional switch: TLE removal or inactivation?","volume":"40","author":"Ramakrishnan","year":"2018","journal-title":"Bioessays"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib179","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gad.260174.115","article-title":"Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis","volume":"29","author":"Rasmussen","year":"2015","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2004-07-2761","article-title":"Apoptosis-based therapies for hematologic malignancies","volume":"106","author":"Reed","year":"2005","journal-title":"Blood"},{"issue":"38","key":"10.1016\/j.critrevonc.2025.104918_bib181","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","article-title":"AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms","volume":"40","author":"Rejeski","year":"2021","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104918_bib182","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1073\/pnas.93.21.11895","article-title":"Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein May contribute to leukemogenesis","volume":"93","author":"Rhoades","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib183","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.bpj.2016.04.045","article-title":"Chaperonin TRiC\/CCT recognizes fusion oncoprotein AML1-ETO through Subunit-Specific interactions","volume":"110","author":"Roh","year":"2016","journal-title":"Biophys. J."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104918_bib184","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4161\/cc.21565","article-title":"Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells","volume":"11","author":"Romanski","year":"2012","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib185","first-page":"109","article-title":"Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia","volume":"16","author":"Rowley","year":"1973","journal-title":"Ann. Genet"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104918_bib186","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2011-10-386086","article-title":"Chromatin accessibility, p300, and histone acetylation define PML-RAR\u03b1 and AML1-ETO binding sites in acute myeloid leukemia","volume":"120","author":"Saeed","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib187","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/bloodadvances.2022008405","article-title":"TIM-3 signaling hijacks the canonical Wnt\/\u03b2-catenin pathway to maintain cancer stemness in acute myeloid leukemia","volume":"7","author":"Sakoda","year":"2023","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib188","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1128\/MCB.01966-07","article-title":"ETO, but not leukemogenic fusion protein AML1\/ETO, augments RBP-Jkappa\/SHARP-mediated repression of notch target genes","volume":"28","author":"Salat","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib189","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13148-014-0034-4","article-title":"Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia","volume":"7","author":"Salmon","year":"2015","journal-title":"Clin. Epigenetics"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib190","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1172\/JCI24225","article-title":"The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice","volume":"115","author":"Schessl","year":"2005","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib191","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/sj.leu.2404830","article-title":"AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia","volume":"21","author":"Schneider","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib192","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.leu.2404465","article-title":"JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)\/ AML1-ETO-positive AML","volume":"21","author":"Schnittger","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib193","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib194","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.2021012778","article-title":"PLCG1 is required for AML1-ETO leukemia stem cell self-renewal","volume":"139","author":"Schnoeder","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib195","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.20020824","article-title":"AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency","volume":"196","author":"Schwieger","year":"2002","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib196","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.leukres.2007.11.038","article-title":"Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias","volume":"32","author":"Serrano","year":"2008","journal-title":"Leuk. Res"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104918_bib197","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1182\/blood-2011-04-347476","article-title":"PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential","volume":"119","author":"Shia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104918_bib198","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.leukres.2016.07.002","article-title":"TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia","volume":"48","author":"Shin","year":"2016","journal-title":"Leuk. Res"},{"key":"10.1016\/j.critrevonc.2025.104918_bib199","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11156","article-title":"Salicylate, diflunisal and their metabolites inhibit CBP\/p300 and exhibit anticancer activity","volume":"5","author":"Shirakawa","year":"2016","journal-title":"Elife"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104918_bib200","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1182\/blood-2009-09-242545","article-title":"AML1\/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein","volume":"117","author":"Steffen","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib201","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41417-021-00329-1","article-title":"Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias","volume":"29","author":"Su","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1541-7786.MCR-22-1035","article-title":"Simultaneous targeting of DNA polymerase theta and PARP1 or RAD52 triggers dual synthetic lethality in homologous Recombination-Deficient leukemia cells","volume":"21","author":"Sullivan-Reed","year":"2023","journal-title":"Mol. Cancer Res"},{"issue":"7460","key":"10.1016\/j.critrevonc.2025.104918_bib203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature12287","article-title":"A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis","volume":"500","author":"Sun","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib204","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/sj.leu.2404924","article-title":"Deregulation of the wilms' tumour gene 1 protein (WT1) by BCR\/ABL1 mediates resistance to imatinib in human leukaemia cells","volume":"21","author":"Svensson","year":"2007","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/sj.cdd.4402139","article-title":"Novel role of HDAC inhibitors in AML1\/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1","volume":"14","author":"Tabe","year":"2007","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib206","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/leu.2017.105","article-title":"Heterodimerization of AML1\/ETO with CBF\u03b2 is required for leukemogenesis but not for myeloproliferation","volume":"31","author":"Thiel","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib207","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17460441.2012.722618","article-title":"DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences","volume":"7","author":"Thomas","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib208","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/jcb.26587","article-title":"AML1\/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer","volume":"119","author":"Tian","year":"2018","journal-title":"J. Cell Biochem"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104918_bib209","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2013-05-500629","article-title":"Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells","volume":"122","author":"Torgersen","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib210","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4161\/auto.26559","article-title":"Autophagy: friend or foe in the treatment of fusion protein-associated leukemias?","volume":"9","author":"Torgersen","year":"2013","journal-title":"Autophagy"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104918_bib211","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood.2020007920","article-title":"Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML","volume":"138","author":"Trinh","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib212","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1096\/fba.2021-00030","article-title":"KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility","volume":"3","author":"Ueda","year":"2021","journal-title":"FASEB Bioadv"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104918_bib213","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2015-04-638494","article-title":"Wnt signaling induces transcription, spatial proximity, and translocation of fusion gene partners in human hematopoietic cells","volume":"126","author":"Ugarte","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib214","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","article-title":"The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia","volume":"101","author":"Vangala","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib215","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.celrep.2016.05.094","article-title":"MEIS2 is an oncogenic partner in AML1-ETO-Positive AML","volume":"16","author":"Vegi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2025.104918_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.10.007","article-title":"A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity","volume":"468","author":"Vicente","year":"2020","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib217","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5703","article-title":"Investigating the biology of microRNA links to ALDH1A1 reveals candidates for preclinical testing in acute myeloid leukemia","volume":"65","author":"Vlahopoulos","year":"2024","journal-title":"Int J. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib218","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/leu.2017.317","article-title":"Targeting acute myeloid leukemia by drug-induced c-MYB degradation","volume":"32","author":"Walf-Vorderw\u00fclbecke","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib219","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4149\/neo_2015_105","article-title":"Increased expression of amyloid precursor protein promotes proliferation and migration of AML1\/ETO-positive leukemia cells and be inhibited by panobinostat","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104918_bib220","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104918_bib221","first-page":"2766","article-title":"Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells","volume":"59","author":"Wang","year":"1999","journal-title":"Cancer Res"},{"issue":"6043","key":"10.1016\/j.critrevonc.2025.104918_bib222","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.1201662","article-title":"The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation","volume":"333","author":"Wang","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib223","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.cdd.4401996","article-title":"Eriocalyxin b induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner","volume":"14","author":"Wang","year":"2007","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104918_bib224","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200026RR","article-title":"Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia","volume":"36","author":"Wang","year":"2022","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib225","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12967-025-06525-z","article-title":"Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104918_bib226","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2147\/IJN.S358469","article-title":"Hydrophilic realgar nanocrystals prolong the survival of refractory acute myeloid leukemia mice through inducing Multi-Lineage differentiation and apoptosis","volume":"17","author":"Wang","year":"2022","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010071","article-title":"AML1-ETO-Related fusion circular RNAs contribute to the proliferation of leukemia cells","volume":"24","author":"Wang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib228","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-020-04358-y","article-title":"Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125","volume":"100","author":"Wang","year":"2021","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104918_bib229","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1073\/pnas.1019625108","article-title":"C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib230","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and C-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to gleevec","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib231","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/leu.2014.179","article-title":"Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1\/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors","volume":"29","author":"Wichmann","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib232","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17050557","article-title":"The molecular chaperone TCP1 affects carcinogenicity and is a potential therapeutic target for acute myeloid leukemia","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.104918_bib233","article-title":"Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia","volume":"13","author":"Xi","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib234","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41408-023-00941-4","article-title":"Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study","volume":"13","author":"Xu","year":"2023","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib235","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.exphem.2007.04.018","article-title":"Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene","volume":"35","author":"Xu","year":"2007","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib236","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1038\/s41467-019-12735-z","article-title":"TAF1 plays a critical role in AML1-ETO driven leukemogenesis","volume":"10","author":"Xu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104918_bib237","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2020.09.031","article-title":"Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia","volume":"327","author":"Yan","year":"2020","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib238","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib239","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2008-04-153742","article-title":"RUNX1\/AML1 DNA-binding domain and ETO\/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis","volume":"113","author":"Yan","year":"2009","journal-title":"Blood"},{"issue":"49","key":"10.1016\/j.critrevonc.2025.104918_bib240","doi-asserted-by":"crossref","first-page":"17186","DOI":"10.1073\/pnas.0406702101","article-title":"Deletion of an AML1-ETO C-terminal NcoR\/SMRT-interacting region strongly induces leukemia development","volume":"101","author":"Yan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib241","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41375-023-02063-z","article-title":"Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation","volume":"38","author":"Yan","year":"2024","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104918_bib242","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1042\/CS20200786","article-title":"Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia","volume":"134","author":"Yang","year":"2020","journal-title":"Clin. Sci. (Lond. )"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib243","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.008904","article-title":"AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression","volume":"135","author":"Yeh","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.critrevonc.2025.104918_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117395","article-title":"Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models","volume":"179","author":"Yen","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib245","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00432-024-05861-9","article-title":"Homoharringtonine May help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia","volume":"150","author":"Yin","year":"2024","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104918_bib246","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41419-019-2080-5","article-title":"FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia","volume":"10","author":"Young","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib247","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.CCR-24-1332","article-title":"Homoharringtonine added to venetoclax and azacitidine improves outcome and mitigates genetic impact in Relapsed\/Refractory AML: a multicenter cohort study","volume":"31","author":"Yu","year":"2025","journal-title":"Clin. Cancer Res"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104918_bib248","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2011.05.014","article-title":"Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor","volume":"35","author":"Yu","year":"2011","journal-title":"Leuk. Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib249","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.154","article-title":"Natural HDAC-1\/8 inhibitor baicalein exerts therapeutic effect in CBF-AML","volume":"10","author":"Yu","year":"2020","journal-title":"Clin. Transl. Med"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104918_bib250","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1158\/0008-5472.CAN-09-1567","article-title":"Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24\/MKP-7\/MAPK network","volume":"69","author":"Zaidi","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib251","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2011.12.041","article-title":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","volume":"319","author":"Zapotocky","year":"2012","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib252","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/MCB.21.1.156-163.2001","article-title":"Oligomerization of ETO is obligatory for corepressor interaction","volume":"21","author":"Zhang","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2025.104918_bib253","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610447","article-title":"A novel BRD family PROTAC inhibitor dBET1 exerts great Anti-Cancer effects by targeting c-MYC in acute myeloid leukemia cells","volume":"28","author":"Zhang","year":"2022","journal-title":"Pathol. Oncol. Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib254","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153768","article-title":"Mosaic loss of chromosome y promotes leukemogenesis and clonal hematopoiesis","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11684-018-0624-1","article-title":"Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia","volume":"13","author":"Zhang","year":"2019","journal-title":"Front Med"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104918_bib256","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1182\/blood-2012-08-447763","article-title":"AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX\/\u03b2-catenin signaling pathway","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104918_bib257","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.sjbs.2017.01.042","article-title":"Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells","volume":"24","author":"Zhang","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib258","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-022-00282-1","article-title":"Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells","volume":"11","author":"Zhao","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"127","key":"10.1016\/j.critrevonc.2025.104918_bib259","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003562","article-title":"Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein","volume":"4","author":"Zhen","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104918_bib260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2016.12.022","article-title":"Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia","volume":"128","author":"Zhou","year":"2017","journal-title":"Biochem Pharm."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib261","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ncb3563","article-title":"AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104918_bib262","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2006-06-032250","article-title":"Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo","volume":"109","author":"Zhou","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104918_bib263","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2010.07.013","article-title":"Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells","volume":"35","author":"Zhou","year":"2011","journal-title":"Leuk. Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104918_bib264","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0067-4","article-title":"Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia","volume":"50","author":"Zhou","year":"2018","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.critrevonc.2025.104918_bib265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exphem.2016.09.013","article-title":"AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia","volume":"46","author":"Zhou","year":"2017","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib266","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","article-title":"A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia","volume":"13","author":"Zhou","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104918_bib267","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.leukres.2016.02.012","article-title":"Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)","volume":"44","author":"Zhu","year":"2016","journal-title":"Leuk. Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104918_bib268","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12032-022-01650-x","article-title":"Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells","volume":"39","author":"Zhuang","year":"2022","journal-title":"Med Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104918_bib269","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/or.2013.2459","article-title":"Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line","volume":"30","author":"Zhuang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104918_bib270","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.1771409","article-title":"Mouse models of human AML accurately predict chemotherapy response","volume":"23","author":"Zuber","year":"2009","journal-title":"Genes Dev."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:53:19Z","timestamp":1792986799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":270,"alternative-id":["S1040842825003063"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104918","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the AML1\/ETO translocation cipher: In-depth exploration into the pathogenesis and cutting-edge therapeutic strategies of t(8;21) acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104918"}}